On ECHEMI
Home > Drugs > Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
  • Founded in:

    1990-08-14
  • Country:

    China China
  • Address:

    No. 1, Qiangyun Road, Economic Development Zone, Miyun District, Beijing
  • Tax NO.:

    91110228102644755T
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Benproperine Phosphate Tablets
Each tablet of this product contains 26.4 mg of the main ingredient, benproperine phosphate (equivalent to 20 mg of benproperine).
Name Description Content CAS NO. Registered Holders
Benproperine phosphate

This product is a non-narcotic antitussive drug that mainly blocks the afferent sensory nerve impulses of the lung and pleural receptors, and also directly inhibits the antitussive center. It also has a papaverine-like smooth muscle spasmolytic effect.

More

This product is a non-narcotic antitussive drug that mainly blocks the afferent sensory nerve impulses of the lung and pleural receptors, and also directly inhibits the antitussive center. It also has a papaverine-like smooth muscle spasmolytic effect.

26.4mg 19428-14-9 19
Proglumide Tablets
Proglumide. Its chemical name is (plusmn;)-5-dipropylamino-4-benzoylamino-5-oxo-pentanoic acid.
Name Description Content CAS NO. Registered Holders
Proglumide

This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, increase the content of hexosamine in gastric mucosa, promote glycoprotein synthesis, protect and promote the healing of gastric mucosa, improve the symptoms of peptic ulcer and promote ulcer healing, and there is no rebound phenomenon of gastric acid secretion after treatment. In addition, this product has a choleretic effect, which can prevent stone formation and promote bile duct health by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK.

More

This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, increase the content of hexosamine in gastric mucosa, promote glycoprotein synthesis, protect and promote the healing of gastric mucosa, improve the symptoms of peptic ulcer and promote ulcer healing, and there is no rebound phenomenon of gastric acid secretion after treatment. In addition, this product has a choleretic effect, which can prevent stone formation and promote bile duct health by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK.

6620-60-6 7
Nitrofurantoin enteric-coated tablets
The main ingredient of this product is nitrofurantoin.
Name Description Content CAS NO. Registered Holders
Nitrofurantoin

This product is an antibacterial drug. Escherichia coli is mostly sensitive to this product, and some strains of Enterobacteriaceae such as Enterobacter aerogenes, Enterobacter cloacae, Proteus, and Klebsiella are sensitive to this product. Aeruginosa is usually resistant to this product. This product has antibacterial effects on Gram-positive bacteria such as Enterococcus. The antibacterial activity of this product is not affected by pus and tissue decomposition products. It is more active in acidic urine. The antibacterial mechanism is to interfere with the oxidoreductase system in the bacteria, thereby blocking its metabolic process.

More

This product is an antibacterial drug. Escherichia coli is mostly sensitive to this product, and some strains of Enterobacteriaceae such as Enterobacter aerogenes, Enterobacter cloacae, Proteus, and Klebsiella are sensitive to this product. Aeruginosa is usually resistant to this product. This product has antibacterial effects on Gram-positive bacteria such as Enterococcus. The antibacterial activity of this product is not affected by pus and tissue decomposition products. It is more active in acidic urine. The antibacterial mechanism is to interfere with the oxidoreductase system in the bacteria, thereby blocking its metabolic process.

67-20-9 26
Griseofulvin Tablets
Griseofulvin
Name Description Content CAS NO. Registered Holders
(+)-Griseofulvin

This product has good antibacterial effect on superficial fungi such as Trichophyton, Microsporum, Epidermophyton, etc. It has no antibacterial effect on Candida, Cryptococcus, Histoplasma, Sporothrix, Blastomyces, Coccidioides, etc. This drug inhibits the growth of fungi by interfering with the synthesis of fungal nucleic acids.

More

This product has good antibacterial effect on superficial fungi such as Trichophyton, Microsporum, Epidermophyton, etc. It has no antibacterial effect on Candida, Cryptococcus, Histoplasma, Sporothrix, Blastomyces, Coccidioides, etc. This drug inhibits the growth of fungi by interfering with the synthesis of fungal nucleic acids.

126-07-8 8
Griseofulvin Tablets
Griseofulvin
Name Description Content CAS NO. Registered Holders
(+)-Griseofulvin

This product has good antibacterial effect on superficial fungi such as Trichophyton, Microsporum, Epidermophyton, etc. It has no antibacterial effect on Candida, Cryptococcus, Histoplasma, Sporothrix, Blastomyces, Coccidioides, etc. This drug inhibits the growth of fungi by interfering with the synthesis of fungal nucleic acids.

More

This product has good antibacterial effect on superficial fungi such as Trichophyton, Microsporum, Epidermophyton, etc. It has no antibacterial effect on Candida, Cryptococcus, Histoplasma, Sporothrix, Blastomyces, Coccidioides, etc. This drug inhibits the growth of fungi by interfering with the synthesis of fungal nucleic acids.

126-07-8 8
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.